2,4-DIAMINO-PYRIMIDINES AS AURORA INHIBITORS

The present invention encompasses compounds of general formula (1) wherein R1 to R3 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a pharmaceutical composition having the above-m...

Full description

Saved in:
Bibliographic Details
Main Authors TONTSCH-GRUNT ULRIKE, TREU MATTHIAS, STADTMUELLER HEINZ, ZAHN STEPHAN KARL, MANTOULIDIS ANDREAS, HERFURTH LARS, REISER ULRICH, BOEHMELT GUIDO, GUERTLER ULRICH, REITHER CHARLOTTE, SCHOOP ANDREAS, KRAEMER OLIVER, SOLCA FLAVIO, BRUECKNER RALPH, ENGELHARDT HARALD
Format Patent
LanguageEnglish
Published 13.10.2011
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention encompasses compounds of general formula (1) wherein R1 to R3 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a pharmaceutical composition having the above-mentioned properties.
Bibliography:Application Number: US201113159787